The growing prevalence of bile duct cancer and the increasing demand for advanced oncology treatments are significantly contributing to the expansion of the global therapeutics market. Rising investments in cancer research, improved diagnostic technologies, and the introduction of targeted therapies are transforming the treatment landscape for cholangiocarcinoma, commonly known as bile duct...

The global chemotherapy market continues to play a critical role in cancer treatment, forming a cornerstone of oncology care worldwide. Despite the emergence of advanced therapies such as immunotherapy and targeted treatments, chemotherapy remains widely used due to its effectiveness across multiple cancer types. The increasing global burden of cancer, coupled with advancements in drug...

According to a newly published market research report by 24LifeSciences, global prostate cancer treatment drugs market was valued at USD 14.03 billion in 2024 and is projected to reach USD 18.74 billion by 2031, growing at a compound annual growth rate (CAGR) of 4.3% during the forecast period 2025-2031. Prostate cancer treatment drugs represent a critical segment in oncology...

Neuroendocrine carcinoma represents a rare and aggressive form of cancer originating from neuroendocrine cells found throughout the body, most commonly in the lungs and gastrointestinal tract.  Evolving Research Dynamics and Clinical AdvancementsOngoing clinical research and innovation in oncology therapeutics are significantly transforming the treatment landscape for neuroendocrine...